» Articles » PMID: 27099765

Cardiovascular Events Prior to or Early After Diagnosis of Systemic Lupus Erythematosus in the Systemic Lupus International Collaborating Clinics Cohort

Abstract

Objective: To describe the frequency of myocardial infarction (MI) prior to the diagnosis of systemic lupus erythematosus (SLE) and within the first 2 years of follow-up.

Methods: The systemic lupus international collaborating clinics (SLICC) atherosclerosis inception cohort enters patients within 15 months of SLE diagnosis. MIs were reported and attributed on a specialised vascular event form. MIs were confirmed by one or more of the following: abnormal ECG, typical or atypical symptoms with ECG abnormalities and elevated enzymes (≥2 times upper limit of normal), or abnormal stress test, echocardiogram, nuclear scan or angiogram. Descriptive statistics were used.

Results: 31 of 1848 patients who entered the cohort had an MI. Of those, 23 patients had an MI prior to SLE diagnosis or within the first 2 years of disease. Of the 23 patients studied, 60.9% were female, 78.3% were Caucasian, 8.7% black, 8.7% Hispanic and 4.3% other. The mean age at SLE diagnosis was 52.5±15.0 years. Of the 23 MIs that occurred, 16 MIs occurred at a mean of 6.1±7.0 years prior to diagnosis and 7 occurred within the first 2 years of follow-up. Risk factors associated with early MI in univariate analysis are male sex, Caucasian, older age at diagnosis, hypertension, hypercholesterolaemia, family history of MI and smoking. In multivariate analysis only age (OR=1.06 95% CI 1.03 to 1.09), hypertension (OR=5.01, 95% CI 1.38 to 18.23), hypercholesterolaemia (OR=4.43, 95% CI 1.51 to 12.99) and smoking (OR=7.50, 95% CI 2.38 to 23.57) remained significant risk factors.

Conclusions: In some patients with lupus, MI may develop even before the diagnosis of SLE or shortly thereafter, suggesting that there may be a link between autoimmune inflammation and atherosclerosis.

Citing Articles

Beyond the Heart: The Predictive Role of Coronary Artery Calcium Scoring in Non-Cardiovascular Disease Risk Stratification.

Cortiana V, Vaghela H, Bakhle R, Santhosh T, Kaiwan O, Tausif A Diagnostics (Basel). 2024; 14(21).

PMID: 39518317 PMC: 11545064. DOI: 10.3390/diagnostics14212349.


Deciphering Mechanisms, Prevention Strategies, Management Plans, Medications, and Research Techniques for Strokes in Systemic Lupus Erythematosus.

Al-Ewaidat O, Naffaa M Medicines (Basel). 2024; 11(7).

PMID: 39189161 PMC: 11348055. DOI: 10.3390/medicines11070015.


Damage in a large systemic lupus erythematosus cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER) with emphasis on the cardiovascular system: a longitudinal analysis.

Altabas-Gonzalez I, Rua-Figueroa I, Mourino C, Roberts K, Jimenez N, Martinez-Barrio J Lupus Sci Med. 2024; 11(2.

PMID: 39097409 PMC: 11331961. DOI: 10.1136/lupus-2023-001064.


Personalizing cardiovascular risk prediction for patients with systemic lupus erythematosus.

Choi M, Guan H, Yoshida K, Paudel M, Kargere B, Li D Semin Arthritis Rheum. 2024; 67:152468.

PMID: 38788567 PMC: 11214838. DOI: 10.1016/j.semarthrit.2024.152468.


Increased cardiovascular risk in Korean patients with systemic lupus erythematosus: a population-based cohort study.

Han J, Cho S, Kim H, Jeon Y, Kang G, Jung S Sci Rep. 2024; 14(1):1082.

PMID: 38212487 PMC: 10784514. DOI: 10.1038/s41598-024-51546-1.


References
1.
Petri M, Perez-Gutthann S, Spence D, Hochberg M . Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med. 1992; 93(5):513-9. DOI: 10.1016/0002-9343(92)90578-y. View

2.
Gladman D, Ang M, Su L, Tom B, Schentag C, Farewell V . Cardiovascular morbidity in psoriatic arthritis. Ann Rheum Dis. 2008; 68(7):1131-5. DOI: 10.1136/ard.2008.094839. View

3.
Gonzalez-Juanatey C, Llorca J, Amigo-Diaz E, Dierssen T, Martin J, Gonzalez-Gay M . High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum. 2007; 57(6):1074-80. DOI: 10.1002/art.22884. View

4.
Abu-Shakra M, Urowitz M, Gladman D, Gough J . Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death. J Rheumatol. 1995; 22(7):1259-64. View

5.
Galkina E, Ley K . Immune and inflammatory mechanisms of atherosclerosis (*). Annu Rev Immunol. 2009; 27:165-97. PMC: 2734407. DOI: 10.1146/annurev.immunol.021908.132620. View